Regeneron Pharmaceuticals, Inc.
REGN NASDAQ







Weekly Report
Regeneron Pharmaceuticals, Inc. closed at 591.9900 (-1.75% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this โ Price slope is upward, indicating persistent buying over the window. Low weekly volatility favours steadier follow-through. Volume trend diverges from price โ watch for fatigue or rotation. Returns are negatively correlated with volume โ strength may come on lighter activity. Distance to baseline is narrowing โ reverting closer to its fair-value track. Constructive MA stack supports the up-drift; pullbacks may find support at the 8โ13 week region. Price holds above key averages, indicating constructive participation.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm. Because liquidity isnโt confirming, prefer evidence of fresh demand before chasing moves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Bearish backdrop but short-term momentum is improving; confirmation still needed.
Early improvement โ look for a reclaim of 0.50โ0.60 to validate.
Conclusion
Positive setup. โ โ โ โ โ confidence. Price window: 5. Trend: Bottoming Attempt; gauge 15. In combination, liquidity diverges from price.
- Early improvement from bearish zone (bottoming attempt)
- Price holds above 8w & 26w averages
- Constructive moving-average stack
- Low return volatility supports durability
- Liquidity diverges from price
Why: Price window 5.93% over 8w. Close is 1.94% above the prior-window high. Return volatility 1.98%. Volume trend falling. Liquidity divergence with price. Trend state bottoming attempt. Low-regime (โค0.25) upticks 5/7 (71.0%) โข Accumulating. MA stack constructive. Momentum neutral and rising.
Tip: Most metrics include a hover tooltip where they appear in the report.